Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jul 14;151(28):1566-73.

[Guideline on polyneuropathy]

[Article in Dutch]
Affiliations
  • PMID: 17715764
Review

[Guideline on polyneuropathy]

[Article in Dutch]
P A van Doorn. Ned Tijdschr Geneeskd. .

Abstract

In the Netherlands, approximately 100,000-400,000 people suffer from polyneuropathy. Polyneuropathy has many different causes, diabetes mellitus being the most frequent one. The practice guideline 'Polyneuropathy' describes the diagnostic procedure in patients with signs or symptoms of polyneuropathy that need to be followed in order to identify the cause of the condition. After history taking and neurological examination, the diagnosis ofpolyneuropathy can be made with a high degree of accuracy. Electrophysiological investigation may be of help, especially in classifying an axonal or demyelinating form of polyneuropathy. This subclassification is important because it helps to identify possibly treatable forms ofpolyneuropathy. Most polyneuropathies follow a slowly progressive course. If the course of the polyneuropathy deviates from what is to be expected, neurological consultation and additional diagnostic tests should be performed. A diagnostic flowchart has been designed to serve as a practical guide to an effective and rapid procedure to diagnose the cause of a polyneuropathy. Amitryptiline and carbamazepine have been proven to be effective and are the drugs of first-choice, except in HIV-related polyneuropathy, in which case only lamotrigine has been proven effective.

PubMed Disclaimer

Comment in

  • [Guideline on polyneuropathy].
    Uijtenbogaart D. Uijtenbogaart D. Ned Tijdschr Geneeskd. 2007 Oct 20;151(42):2355-6; author reply 2356. Ned Tijdschr Geneeskd. 2007. PMID: 18064945 Dutch. No abstract available.

Similar articles

Cited by

LinkOut - more resources